CoChat

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

Open access
Jatlaoui, Tara C., Wiltz, Jennifer L., Kabbani, Sarah, Siegel, David A., Koppaka, Ram, Montandon, Michele, Adkins, Susan Hocevar, Weissman, David N., Koumans, Emily H., O’Hegarty, Michelle, O’Sullivan, Megan C., Ritchey, Matthew D., Chatham-Stephens, Kevin, Kiernan, Emily A., Layer, Mark, Reagan-Steiner, Sarah, Legha, Jaswinder K., Shealy, Katherine, King, Brian A., Jones, Christopher M., Baldwin, Grant T., Rose, Dale A., Delaney, Lisa J., Briss, Peter, Evans, Mary E., Lung Injury Response Clinical Working Group, Lung Injury Response Clinical Working Group, Aberegg, Scott, Calfee, Carolyn S., Callahan, Sean J., Esper, Annette, Griffiths, Anne, Harris, Dixie, Hayes, Don, Rao, Devika R., Smith, Lincoln S. · 2019 · MMWR. Morbidity and Mortality Weekly Report
Cited by 96

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). CDC has published recommendations for health care providers regarding EVALI (2-4). Recently, researchers from Utah and New York published proposed diagnosis and treatment algorithms for EVALI (5,6). EVALI remains a diagnosis of exclusion because, at present, no specific test or marker exists for its diagnosis, and evaluation should be guided by clinical judgment. Because patients with EVALI can experience symptoms similar to those associated with influenza or other respiratory infections (e.g., fever, cough, headache, myalgias, or fatigue), it might be difficult to differentiate EVALI from influenza or community-acquired pneumonia on initial assessment; EVALI might also co-occur with respiratory infections. This report summarizes recommendations for health care providers managing patients with suspected or known EVALI when respiratory infections such as influenza are more prevalent in the community than they have been in recent months (7). Recommendations include 1) asking patients with respiratory, gastrointestinal, or constitutional symptoms about the use of e-cigarette, or vaping, products; 2) evaluating those suspected to have EVALI with pulse oximetry and obtaining chest imaging, as clinically indicated; 3) considering outpatient management for clinically stable EVALI patients who meet certain criteria; 4) testing patients for influenza, particularly during influenza season, and administering antimicrobials, including antivirals, in accordance with established guidelines; 5) using caution when considering prescribing corticosteroids for outpatients, because this treatment modality has not been well studied among outpatients, and corticosteroids could worsen respiratory infections; 6) recommending evidence-based treatment strategies, including behavioral counseling, to help patients discontinue using e-cigarette, or vaping, products; and 7) emphasizing the importance of annual influenza vaccination for all persons aged ≥6 months, including patients who use e-cigarette, or vaping products.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.mm6846e2

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 96

Metadata

Authors
Jatlaoui, T. C., Wiltz, J. L., Kabbani, S., Siegel, D. A., Koppaka, R., Montandon, M., Adkins, S. H., Weissman, D. N., Koumans, E. H., O’Hegarty, M., O’Sullivan, M. C., Ritchey, M. D., Chatham-Stephens, K., Kiernan, E. A., Layer, M., Reagan-Steiner, S., Legha, J. K., Shealy, K., King, B. A., Jones, C. M., Baldwin, G. T., Rose, D. A., Delaney, L. J., Briss, P., Evans, M. E., Lung Injury Response Clinical Working Group, Lung Injury Response Clinical Working Group, Aberegg, S., Calfee, C. S., Callahan, S. J., Esper, A., Griffiths, A., Harris, D., Hayes, D., Rao, D. R., & Smith, L. S.
Venue
MMWR. Morbidity and Mortality Weekly Report
Published
2019-11-22
Volume
68
Issue
46
Pages
1081-1086
ISSN
  • 0149-2195 (ISSN-L)
  • 1545-861X
OpenAlex
W2991052249
Cited by
96
References
6
FWCI
10.72
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019. https://app.cochat.ai/papers/10.15585/mmwr.mm6846e2
The paper
Jatlaoui, T. C., Wiltz, J. L., Kabbani, S., Siegel, D. A., Koppaka, R., Montandon, M., Adkins, S. H., Weissman, D. N., Koumans, E. H., O’Hegarty, M., O’Sullivan, M. C., Ritchey, M. D., Chatham-Stephens, K., Kiernan, E. A., Layer, M., Reagan-Steiner, S., Legha, J. K., Shealy, K., King, B. A., . . . Smith, L. S. (2019). Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6846e2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.